Palomino Laboratories Inc. (OTC:PALX)
| Market Cap | 376.90M+983.3% |
| Revenue (ttm) | n/a |
| Net Income | n/a-745.7% |
| EPS | n/a+13.3% |
| Shares Out | 23.19M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,000 |
| Open | 15.92 |
| Previous Close | 16.24 |
| Day's Range | 15.92 - 16.25 |
| 52-Week Range | 1.50 - 18.10 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
About PALX
Palomino Laboratories, Inc. is a semiconductor and optical communications company. It engages in the provision of developing high-speed, energy-efficient data transfer technologies for AI data centres, cloud computing, and computing systems. It specializes in gallium nitride (GaN) MicroLED-based optical interconnect solutions designed to replace traditional copper wiring and improve bandwidth, latency, and power efficiency in next-generation computing infrastructure. The company was founded by Jeffrey B. Shealy and Steven Den Baarson March 10, 2022 and is headquartered in Goleta, CA.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$PALX stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in PALX holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by PALX's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
PALX Estimated quarterly lobbying spending
Source: U.S. Senate LDA
PALX Revenue by Segment
| Segment | Revenue | % of All |
|---|---|---|
| Other | $258.40K | 42.62% |
| Accounting and other professional fees | $181.77K | 29.98% |
| Payroll and benefits | $142.00K | 23.42% |
| Legal fees | $24.12K | 3.98% |
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New PALX patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to PALX from public contracts
Source: USAspending.gov
PALX Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from PALX’s recent data — informational, not investment advice